Page 1 of 11, showing 50 records out of 506 total, starting on record 1, ending on 50
| Year(s) |
Title |
|
2008 |
13th World Congress of Gynecological Endocrinology, “Aromatase as key regulator of intracrinology”, Florence, February 2008 |
|
2008 |
Tokyo expert meeting. “Combined androgen blockade should be the only hormone therapy used in prostate cancer”. Tokyo, April 2008 |
|
2008 |
96th Annual Meeting of the Japan Urological Association, “Dream of antiandrogens therapy for prostate cancer”, Yokohama, April 2008 |
|
2008 |
Workshop on Pre-receptor steroid metabolism as target for pharmacological treatment –“Intracrinology, pre-receptor control of intracellular active steroid concentration,”, Munich, May 2008 |
|
2008 |
The Endocrine Society’s 90th Annual Meeting, “Clinical aspects of Aromatase Inhibitor Resistance”, San Francisco, June 2008 |
|
2008 |
13 International Congress on Hormonal Steroids and Hormones & Cancer, “ Prostate Cancer”, Quebec, September 2008 |
|
2008 |
Multidisciplinary International Conference, “Androgens and breast cancer”, Pisa, October 2008 |
|
2008 |
18th International symposium of the Journal of Steroid Biochemistry and Molecular Biology, “Intracrinology at the basis of tissue-specific hormone replacement therapy”, Seefeld, Tyrol, sept 2008 |
|
2007 |
Symposia, State of the ART speaker, International Society for the study of Women’s Sexual Health (ISSWS), “The major role of extragonadal sex steroid formation in women, especially after menopause”, O |
|
2007 |
The Breast, First International Congress on Breast Development, Functions and Diseases, Turin, Lingotto Convention Center, September 27-30, 2007 |
|
2007 |
21st World congress of Dermatology, “Sophisticated steroid-making machinery of the skin”, Buenos aires, October 2007 |
|
2007 |
The King Faisal Memorial Lecture series in medicine (2007), “The remarkable success of hormone therapy of prostate cancer in 2007, King ABD Al-Aziz City for Science and Technology, Auditorium Riyadh, |
|
2006 |
CBI Conference on Menopause Pharmacotherapeutic Development “Tissue-specific HRT combining prevention of breast cancer”, Philadelphia, January 2006 |
|
2006 |
International Society of Gynecological Endocrinology Symposium on “The role of androgens in female sexual function” – “Current knowledge of androgens in breast cancer”, Florence, March 2006. |
|
2006 |
Menopause Conference, Center for Business Intelligence, Menopause Pharmacotherapeutic Development – Current Trends, Challenges and Scientific Advances for Drug Development for Menopause and Related Is |
|
2006 |
Les Nouvelles Approches au Bien Vieillir des Femmes – Symposium Canada-France “Femmes et veillessement – rôle des hormones », Nice, March 2006. |
|
2006 |
Biomedex 2006 – Success in technology transfer: the first 18 months – Proof of concept, Montreal, May 2006. |
|
2006 |
Androgen Excess Society – 4th Annual Meeting “Role of the adrenal in androgen excess in women”, Boston, June 2006. |
|
2006 |
2006 Prostate Cancer Update at the occasion of Dacapeptyl’s 20th Anniversary, “The multiple intracrine targets in the prostate: opportunities and challenges”, Budapest, September 2006 |
|
2006 |
Gunma University Urological meeting, “The key role of combined androgen blockade in prostate cancer”, Tagasaki, October 2006 |
|
2006 |
The Endocrine Society’s 88th Annual meeting, meeting of the Androgen Excess Society “Physiology and role of androgen in women”, Boston, June 2006 |
|
2005 |
International Symposium –Scientific Advisory Board and Faculty, 8th International Symposium on GnRH analogues in cancer and human reproduction, Salzburg, Austria, February 2005. |
|
2005 |
10th Yearly meeting of the International Menopause Forum Tuohilampi (IMFT) “What about the importance of androgens in women”, Hamburg, June 2005 |
|
2005 |
7th European Congress of Endocrinology – HRT-clinical management « SERMs and future perspectives », Göteborg, September 2005. |
|
2005 |
International Solamer Symposium « Biologie moléculaire, génomique et nouvelle médecine de la ménopause », Québec, (octobre 2005) |
|
2005 |
Pleanary lecture: Symposium of FMC SOGC/AOGQ/SOLAMER – Quel sera l’impact de la biologie moléculaire dans notre pratique? Québec, October 2005. |
|
2005 |
The WADA Symposium on Gene Doping, “DHEA is an anabolic steroid like testosterone and THG”, Stockholm, December 2005. |
|
2005 |
2005 Prostate Cancer Symposium of the American Society of Clinical Oncology (ASCO), the American Society of Therapeutic Radiology and Oncology (ASTRO), the Society of Urologic Oncology (SUO) and the P |
|
2004 |
International Menopause Forum Tuohilampi, “The role of androgens for the female health and for the breast“, Vienne (June 2004) |
|
2004 |
Sex Steroids: An Update of Estrogen and Progesterone Actions – Role in Cancer, Ageing and Reproductive Medicine, Recent Data from Research to Clinical Practice, “Third Generation SERMs?” Montpellier ( |
|
2004 |
4e World Conférence of Science Journalists (WCS) Genomics of Common diseases/Génomique et maladies, « Genome of Hormone-Sensitive Diseases », Montréal (Octobre 2004) |
|
2004 |
3rd International Symposium, "The Science and Technology of Skin Engineering" - "Hormonal Equipment in Skin In Vitro", “The skin as an important site of local formation and action of sex steroids”, La |
|
2004 |
Women’s Health Symposium, 50th Annual Meeting of the Canadian Fertility and Andrology Society, “SERMs as Part of Novel HRT“, Jasper (November 2004) |
|
2004 |
Van Campenhout Lecture, 50th Anual Meeting of the Canadian Fertility and Andrology Society, “Androgens and Sex Steroid Physiology in Women“, Jasper (November 2004) |
|
2003 |
Genome Canada-Genome Espana Meeting, “Atlas of Genomic Profiles of Steroid Action”, Madrid (January 2003) |
|
2003 |
7th International Symposium on GnRH Analogues in Cancer and Human Reproduction, “Androgen Blockage in Prostate Cancer – Possibility of Cure in Localized Disease”, Amsterdam (February 2003) |
|
2003 |
Symposium: Nouveautés en Endocrinologie 2003, Association des médecins endocrinologues du Québec, “DHEA dans le traitement de la ménopause et de l’insuffisance surrénalienne” Montérégie (February 2003 |
|
2003 |
Plenary Lecture, New Frontiers in Neuroendocrinology, “New Frontiers in the Biology and Therapy of Prostate and Breast Cancer”, Milan (March 2003) |
|
2003 |
Journées Klotz 2003, Journées internationales d’Endocrinologie de la ménopause et de l’andropause, “Synthèse extragonadique des stéroïdes sexuels: l’intracrinologie”, Paris (April 2003) |
|
2003 |
Serono Foundation for the Advancement of Medical Science Workshop on Molecular Steroidogenesis, “Steroid Formation in Target Intracine Tissues”, Bath, UK (April 2003) |
|
2003 |
93th Annual Meeting of the American Urological Association, Takeda Evening Seminar on “Future Prospects for Primary Hormone Therapy in Localized and Locally Advanced Prostate Cancer”, The very high ef |
|
2003 |
Genome Canada Symposium, “Atlas of Genomic Profiles of Steroid Action Response in Health and in Immune-Related Disorders”, Toronto (September 2003) |
|
2003 |
FSD Expert Panel Meeting, “Physiology of Sex Steroid Hormones in Women”, Amsterdam (octobre 2003) |
|
2003 |
53rd Annual Meeting of the Central Division of the Japan Urological Association, “Recent Progress in Hormonal Treatment of Prostate Cancer”, Kanazawa (November 2003) |
|
2003 |
Institute of Biochemistry and Cell Biology (IBCB), Shanghai (November 2003) |
|
2002 |
15th Annual Midwest Cancer Symposium, Urologic Malignancies – State of the Art 2002, Rush-Copley Cancer Center, “Combined Androgen Blockade in the Treatment of Prostate Cancer”, Oakbrook, Ill. (April |
|
2002 |
Norwegian Society for Endocrinology, “DHEA as Precursor of Androgens and Estrogens in Peripheral Target Tissues: Intracrinology” Tromso, Norway (March 2002) |
|
2002 |
12th International Prostate Cancer Update, “Susceptibility Genes for Prostate Cancer”, Keystone (February 2002) |
|
2002 |
12th International Prostate Cancer Update, “The Quebec Screening Study – 11-Year Follow-up”, Keystone (February 2002) |
|
2002 |
National Genomics Conference – Genome Canada, “Atlas of Genomic Profiles of Steroid Action”, Montreal (May 2002) |